Healthcare giant Johnson & Johnson plans to build 4 new international innovation centers to pick up local innovators and foster early-stage deals.
Johnson & Johnson (NYSE:JNJ) is looking to re-energize its early-stage deal-making with the launch of 4 new international innovation centers, fully equipped with J&J science and technology experts focused on emerging opportunities.
Opening in Boston, San Francisco, London and China, the centers are part of a novel J&J initiative to "accelerate early innovation and enhance opportunities for collaboration and investment across its global healthcare businesses," according to a company statement.
"As a leading healthcare company in the world, our goal is to have continuous access to the best science and technology in the world," worldwide pharma chairman and incoming chief scientific officer Dr. Paul Stoffels said in prepared remarks. "The innovation centers allow us to be closer to where the innovation occurs, to access and invest in the best early-stage science and technology, and to fuel our business as well as the health of the innovation ecosystem overall."